Overdiagnosis in contexto of cancer
DOI:
https://doi.org/10.33448/rsd-v11i12.34071Keywords:
Tracking systems; Overdiagnosis; Neoplasms.Abstract
Introduction: Overdiagnosis is characterized by the unnecessary diagnosis of pathologies in asymptomatic patients through screening programs or routine exams, a pathology that would not lead to serious symptoms or death. Objective: To review the literature on Overdiagnosis in the context of cancer and how this practice impacts the lives of patients, as well as the health system and public spending. Methods: An integrative review of the literature on Overdiagnosis in the context of cancer carried out in the LILACS, SCIELO, MEDLINE and PubMED databases from January to May 2021, with full and original articles selected in Portuguese, English and Spanish. Results: 24 articles were selected that address the issue of Overdiagnosis in the context of prostate, breast, thyroid, lung and bowel cancer. Conclusion: The studies show the impact of Overdiagnosis in the early diagnosis of cancer, a fact that directly affects the psychological health of the patient and the expenses of the health system. There is a need for further research in order to find new ways of screening for cancer to reduce the risks to the health of the population and redirect the government budget to really necessary situations.
References
Ahdoot, M., Wilbur, A. R., Reese, S. E., Lebastchi, A. H., Mehralivand, S., Gomella, P. T., . . . Pinto, P. A. (2020). MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. 382(10), 917-928. https://doi.org/10.1056/NEJMoa1910038
Andriole, G. L., Crawford, E. D., Grubb, R. L., 3rd, Buys, S. S., Chia, D., Church, T. R., . . . Berg, C. D. (2009). Mortality results from a randomized prostate-cancer screening trial. N Engl J Med, 360(13), 1310-1319. https://doi.org/10.1056/NEJMoa0810696
Araújo, F. A. G. d. R., Sumita, N. M., & Barroso, U. d. O. J. I. b. j. u. (2019). A continuous fall of PSA use for prostate cancer screening among Brazilian doctors since 2001. Good or bad notice? , 45, 478-485.
Armstrong, N. (2021). Overdiagnosis and overtreatment: a sociological perspective on tackling a contemporary healthcare issue. 43(1), 58-64. https://doi.org/https://doi.org/10.1111/1467-9566.13186
Autier, P., Boniol, M., Middleton, R., Doré, J. F., Héry, C., Zheng, T., & Gavin, A. (2011). Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol, 22(8), 1726-1735. https://doi.org/10.1093/annonc/mdq633
Beckmann, K., Duffy, S. W., Lynch, J., Hiller, J., Farshid, G., & Roder, D. (2015). Estimates of over-diagnosis of breast cancer due to population-based mammography screening in South Australia after adjustment for lead time effects. J Med Screen, 22(3), 127-135. https://doi.org/10.1177/0969141315573978
Benderska-Söder, N., Hovanec, J., Pesch, B., Goebell, P. J., Roghmann, F., Noldus, J., . . . Schmitz-Dräger, B. J. (2020). Toward noninvasive follow-up of low-risk bladder cancer - Rationale and concept of the UroFollow trial. Urol Oncol, 38(12), 886-895. https://doi.org/10.1016/j.urolonc.2020.01.006
Bergdahl, A. G., Wilderäng, U., Aus, G., Carlsson, S., Damber, J.-E., Frånlund, M., . . . Stranne, J. J. E. u. (2016). Role of magnetic resonance imaging in prostate cancer screening: a pilot study within the Göteborg randomised screening trial. 70(4), 566-573.
Bleijenberg, A. G., JE, I. J., van Herwaarden, Y. J., Carballal, S., Pellisé, M., Jung, G., . . . Dekker, E. (2020). Personalised surveillance for serrated polyposis syndrome: results from a prospective 5-year international cohort study. Gut, 69(1), 112-121. https://doi.org/10.1136/gutjnl-2018-318134
Blom, E. F., Ten Haaf, K., & de Koning, H. J. (2020). Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates. Lung Cancer, 139, 200-206. https://doi.org/10.1016/j.lungcan.2019.11.024
Carter, S. M., & Barratt, A. (2017). What is overdiagnosis and why should we take it seriously in cancer screening? http://hdl.handle.net/2123/17022
Charvin, M., Launoy, G., & Berchi, C. (2020). The effect of information on prostate cancer screening decision process: a discrete choice experiment. BMC Health Services Research, 20(1), 467. https://doi.org/10.1186/s12913-020-05327-x
Cho, H. N., Choi, E., Seo, D. H., Park, B., Park, S., Cho, J., . . . Choi, K. S. (2019). Determinants of undergoing thyroid cancer screening in Korean women: a cross-sectional analysis from the K-Stori 2016. BMJ Open, 9(4), e026366. https://doi.org/10.1136/bmjopen-2018-026366
Choi, S. W., Ryu, S. Y., Han, M. A., & Park, J. (2018). Higher breast cancer prevalence associated with higher socioeconomic status in the South Korean population; Has it resulted from overdiagnosis? PLOS ONE, 13(7), e0200484. https://doi.org/10.1371/journal.pone.0200484
Coll-Benejam, T., Bravo-Toledo, R., Marcos-Calvo, M. P., & Astier-Peña, M. P. (2018). Impact of overdiagnosis and overtreatment on the patient, the health system and society [Impacto del sobrediagnóstico y sobretratamiento en el paciente, el sistema sanitario y la sociedad]. Atencion primaria, 50 Suppl 2(Suppl 2), 86-95. https://doi.org/10.1016/j.aprim.2018.08.004
Degeling, C., Barratt, A., Aranda, S., Bell, R., Doust, J., Houssami, N., . . . Carter, S. M. (2018). Should women aged 70–74 be invited to participate in screening mammography? A report on two Australian community juries. BMJ Open, 8(6), e021174. https://doi.org/10.1136/bmjopen-2017-021174
Duffy, S., Vulkan, D., Cuckle, H., Parmar, D., Sheikh, S., Smith, R., . . . Moss, S. (2020). Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Health Technol Assess, 24(55), 1-24. https://doi.org/10.3310/hta24550
Glasziou, P. P., Jones, M. A., Pathirana, T., Barratt, A. L., & Bell, K. J. (2020). Estimating the magnitude of cancer overdiagnosis in Australia. Med J Aust, 212(4), 163-168. https://doi.org/10.5694/mja2.50455
González Maldonado, S., Motsch, E., Trotter, A., Kauczor, H. U., Heussel, C. P., Hermann, S., . . . Kaaks, R. (2021). Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial. Int J Cancer, 148(5), 1097-1105. https://doi.org/10.1002/ijc.33295
Hersch, J., McGeechan, K., Barratt, A., Jansen, J., Irwig, L., Jacklyn, G., . . . McCaffery, K. (2017). How information about overdetection changes breast cancer screening decisions: a mediation analysis within a randomised controlled trial. BMJ Open, 7(10), e016246. https://doi.org/10.1136/bmjopen-2017-016246
Jacklyn, G., Glasziou, P., Macaskill, P., & Barratt, A. (2016). Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography. Br J Cancer, 114(11), 1269-1276. https://doi.org/10.1038/bjc.2016.90
Janovsky, C. C. P. S., Bittencourt, M. S., Novais, M. A. P. d., Maciel, R., Biscolla, R. P. M., Zucchi, P. J. A. o. E., & Metabolism. (2018). Thyroid cancer burden and economic impact on the Brazilian public health system. 62, 537-544.
Jegerlehner, S., Chiolero, A., Aujesky, D., Rodondi, N., Germann, S., Konzelmann, I., . . . One, N. W. G. J. P. (2019). Recent incidence and surgery trends for prostate cancer: Towards an attenuation of overdiagnosis and overtreatment? , 14(2), e0210434.
Kovac, E., Carlsson, S. V., Lilja, H., Hugosson, J., Kattan, M. W., Holmberg, E., & Stephenson, A. J. J. J. n. o. (2020). Association of baseline prostate-specific antigen level with long-term diagnosis of clinically significant prostate cancer among patients aged 55 to 60 years: a secondary analysis of a cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. 3(1), e1919284-e1919284.
Kundra, A., Goldstein, D. P., Wintemute, K., Ghai, S., Tsang, R. W., Gupta, K., . . . Sawka, A. M. (2019). A pilot study examining Toronto-area family physician perspectives on thyroid neoplasm evaluation. Journal of Otolaryngology - Head & Neck Surgery, 48(1), 24. https://doi.org/10.1186/s40463-019-0349-4
Martin, R. M., Donovan, J. L., Turner, E. L., Metcalfe, C., Young, G. J., Walsh, E. I., . . . Group, f. t. C. T. (2018). Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial. JAMA, 319(9), 883-895. https://doi.org/10.1001/jama.2018.0154 %J JAMA
Mendes, K. D. S., Silveira, R. C. d. C. P., Galvão, C. M. J. T., & contexto-enfermagem. (2008). Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. 17, 758-764.
Migowski, A., Silva, G. A., Dias, M. B. K., Diz, M. D. P. E., Sant’Ana, D. R., & Nadanovsky, P. J. C. d. S. P. (2018). Diretrizes para detecção precoce do câncer de mama no Brasil. II-Novas recomendações nacionais, principais evidências e controvérsias. 34, e00074817.
Modesto, A. A. D. A., Lima, R. L. B. d., D’Angelis, A. C., & Augusto, D. K. J. I.-C., Saúde, Educação. (2017). Um novembro não tão azul: debatendo rastreamento de câncer de próstata e saúde do homem.
Moss, J. L., Roy, S., Shen, C., Cooper, J. D., Lennon, R. P., Lengerich, E. J., . . . Ruffin, M. T. t. (2020). Geographic Variation in Overscreening for Colorectal, Cervical, and Breast Cancer Among Older Adults. JAMA Netw Open, 3(7), e2011645. https://doi.org/10.1001/jamanetworkopen.2020.11645
O'Grady, T. J., Gates, M. A., & Boscoe, F. P. (2015). Thyroid cancer incidence attributable to overdiagnosis in the United States 1981-2011. Int J Cancer, 137(11), 2664-2673. https://doi.org/10.1002/ijc.29634
Pastorino, U., Silva, M., Sestini, S., Sabia, F., Boeri, M., Cantarutti, A., . . . Marchianò, A. (2019). Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol, 30(7), 1162-1169. https://doi.org/10.1093/annonc/mdz117
Pastorino, U., Sverzellati, N., Sestini, S., Silva, M., Sabia, F., Boeri, M., . . . Marchianò, A. (2019). Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening. Eur J Cancer, 118, 142-148. https://doi.org/10.1016/j.ejca.2019.06.009
Pinsky, P. F., Prorok, P. C., Yu, K., Kramer, B. S., Black, A., Gohagan, J. K., . . . Andriole, G. L. (2017). Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years. Cancer, 123(4), 592-599. https://doi.org/10.1002/cncr.30474
Riganti, P., Discacciati, V., Terrasa, S., & Kopitowski, K. J. R. A. d. S. P. (2018). Factores motivacionales que influyen sobre las mujeres en la realización de mamografías de tamizaje de cáncer de mama. 9(37), 22-28.
Silva., I. N. d. C. J. A. G. d. (2020). ABC do câncer : abordagens básicas para o controle do câncer / Instituto Nacional
de Câncer José Alencar Gomes da Silva.
Soares, S. C. M., de Camargo Cancela, M., Migowski, A., & de Souza, D. L. B. (2019). Digital rectal examination and its associated factors in the early detection of prostate cancer: a cross-sectional population-based study. BMC Public Health, 19(1), 1573. https://doi.org/10.1186/s12889-019-7946-z
Souza, M. T. d., Silva, M. D. d., & Carvalho, R. d. J. E. (2010). Revisão integrativa: o que é e como fazer. 8, 102-106.
Tesser, C. D., & d'Ávila, T. L. d. C. (2016). Por que reconsiderar a indicação do rastreamento do câncer de mama? J Cadernos de Saúde Pública, 32.
Toscas, F. S., & Toscas, F. J. R. B. (2015). Sobrediagnóstico e suas implicações na engenharia clínica. 23, 535-541.
Vaccarella, S., Franceschi, S., Bray, F., Wild, C. P., Plummer, M., & Dal Maso, L. (2016). Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis. N Engl J Med, 375(7), 614-617. https://doi.org/10.1056/NEJMp1604412
Welch, H. G., & Black, W. C. (2010). Overdiagnosis in Cancer. JNCI: Journal of the National Cancer Institute, 102(9), 605-613. https://doi.org/10.1093/jnci/djq099
Welch, H. G., Kramer, B. S., & Black, W. C. (2019). Epidemiologic Signatures in Cancer. 381(14), 1378-1386. https://doi.org/10.1056/NEJMsr1905447
Welch, H. G., Prorok, P. C., O’Malley, A. J., & Kramer, B. S. (2016). Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. 375(15), 1438-1447. https://doi.org/10.1056/NEJMoa1600249
Wu, W. Y., Törnberg, S., Elfström, K. M., Liu, X., Nyström, L., & Jonsson, H. (2018). Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up. Breast Cancer Res, 20(1), 153. https://doi.org/10.1186/s13058-018-1082-z
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Guilherme Sampaio Silva ; Vitor Matias Grah; Jordana Gasparelo Santi; Bruno Sousa Borges; Ediane Teixeira Lima Silva; Gabrielle Barcelo Paes; Simone Galli Rocha Bragato; Maria Olimpia Ribeiro do Vale Almada
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
